Daiwa Securities Group’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7K | Hold |
63
| – | – | ﹤0.01% | 1135 |
|
2025
Q1 | $7K | Hold |
63
| – | – | ﹤0.01% | 1112 |
|
2024
Q4 | $7K | Hold |
63
| – | – | ﹤0.01% | 1148 |
|
2024
Q3 | $6K | Hold |
63
| – | – | ﹤0.01% | 1159 |
|
2024
Q2 | $5K | Hold |
63
| – | – | ﹤0.01% | 1192 |
|
2024
Q1 | $5K | Hold |
63
| – | – | ﹤0.01% | 1203 |
|
2023
Q4 | $4K | Hold |
63
| – | – | ﹤0.01% | 1217 |
|
2023
Q3 | $4K | Hold |
63
| – | – | ﹤0.01% | 1170 |
|
2023
Q2 | $5K | Hold |
63
| – | – | ﹤0.01% | 1173 |
|
2023
Q1 | $5K | Hold |
63
| – | – | ﹤0.01% | 1145 |
|
2022
Q4 | $4K | Sell |
63
-38
| -38% | -$2.41K | ﹤0.01% | 1162 |
|
2022
Q3 | $5K | Hold |
101
| – | – | ﹤0.01% | 1153 |
|
2022
Q2 | $6K | Buy |
101
+22
| +28% | +$1.31K | ﹤0.01% | 1151 |
|
2022
Q1 | $6K | Hold |
79
| – | – | ﹤0.01% | 1154 |
|
2021
Q4 | $8K | Sell |
79
-12
| -13% | -$1.22K | ﹤0.01% | 1155 |
|
2021
Q3 | $8K | Buy |
91
+38
| +72% | +$3.34K | ﹤0.01% | 1150 |
|
2021
Q2 | $4K | Hold |
53
| – | – | ﹤0.01% | 1086 |
|
2021
Q1 | $5K | Buy |
53
+5
| +10% | +$472 | ﹤0.01% | 1075 |
|
2020
Q4 | $3K | Sell |
48
-99
| -67% | -$6.19K | ﹤0.01% | 1086 |
|
2020
Q3 | $9K | Hold |
147
| – | – | ﹤0.01% | 1038 |
|
2020
Q2 | $7K | Hold |
147
| – | – | ﹤0.01% | 1073 |
|
2020
Q1 | $7K | Sell |
147
-12
| -8% | -$571 | ﹤0.01% | 1071 |
|
2019
Q4 | $10K | Sell |
159
-38
| -19% | -$2.39K | ﹤0.01% | 1054 |
|
2019
Q3 | $12K | Hold |
197
| – | – | ﹤0.01% | 1012 |
|
2019
Q2 | $14K | Sell |
197
-11
| -5% | -$782 | ﹤0.01% | 1021 |
|
2019
Q1 | $16K | Buy |
208
+20
| +11% | +$1.54K | ﹤0.01% | 990 |
|
2018
Q4 | $16K | Hold |
188
| – | – | ﹤0.01% | 969 |
|
2018
Q3 | $32K | Hold |
188
| – | – | ﹤0.01% | 969 |
|
2018
Q2 | $24K | Hold |
188
| – | – | ﹤0.01% | 998 |
|
2018
Q1 | $19K | Buy |
+188
| New | +$19K | ﹤0.01% | 982 |
|